Grown Rogue International (GRUSF) Assets Growth (1y) (2010 - 2026)
Grown Rogue International (GRUSF) Assets Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.35% |
| Sep 30, 2025 | 184,514,363.33% |
| Mar 31, 2025 | 25.69% |
| Apr 30, 2021 | 128.58% |
| Jan 31, 2021 | 80.07% |
| Oct 31, 2020 | 28.37% |
| Jan 31, 2020 | -51.38% |
| Oct 31, 2019 | -45.35% |
| Oct 31, 2018 | 84.12% |
| Aug 31, 2018 | -22.70% |
| May 31, 2018 | -87.78% |
| Feb 28, 2018 | -76.43% |
| Nov 30, 2017 | -71.61% |
| Aug 31, 2017 | -91.22% |
| May 31, 2017 | -98.81% |
| Feb 28, 2017 | -98.67% |
| Nov 30, 2016 | 254.15% |
| Aug 31, 2016 | 409.89% |
| May 31, 2016 | 702.48% |
| Feb 29, 2016 | 35.88% |